Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    2013
    >
    March
    >
    8

    Day: March 8, 2013

    March 8, 2013in Access to Medicines, Competition, Human Rights, IP, Patent Practice, Patentability, Patents1by Editor
    834

    The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents

    The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad…

    Read more
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736